286: FTC v. biotech, Pfizer's kitchen sink, & Vertex's future
First, we delve into the fallout over the FTC's move to block what looked like a humdrum biotech deal between Sanofi and Maze Therapeutics, a surprising twist that leaves unanswered question. We also discuss the latest news in the life sciences, including Pfizer\u2019s downbeat future, Vertex Pharmaceuticals\u2019 next big thing, and a newly minted biotech VC with a very famous name.\n\nHere's where you can subscribe to our biotech newsletter, The Readout.